FOCLEDAP TMS S.A. American Depositary SharesHealthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $4.07 · now $4.07 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, FOCL has typically landed between $3.16 and $5.20 — a range of −22.5% to +27.7% from the issuance price $4.07.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,001 overlapping 1 month windows · 2006-09-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($4.07) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where FOCL has typically landed a month from the 2026-09-16 close of $4.07 — the range is history, not a prediction.

$3.16worst · -22.5%$5.2best · +27.7%
  • now $4.07 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $3.99 (-2.0%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $3.54$4.44
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $3.16$5.2
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,001 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2014-07-08−73.5%−73.5%+0.0%
2014-07-14−73.4%−74.7%+0.0%
2014-07-11−73.1%−74.2%+1.8%
3 best
2009-08-12+259.2%−0.8%+259.2%
2009-08-13+254.3%+0.0%+262.0%
2009-08-14+229.2%+0.0%+259.2%

5,001 overlapping windows · 2006-09-262026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
60%
+10.4%
n=20
Feb
65%
+6.6%
n=20
Mar
30%
−5.5%
n=20
Apr
35%
+0.2%
n=20
May
55%
−0.1%
n=20
Jun
35%
+0.9%
n=20
Jul
35%
−2.1%
n=20
Aug
30%
+6.2%
n=20
Sep
50%
−0.1%
n=20
Oct
40%
−0.4%
n=20
Nov
45%
+3.8%
n=20
Dec
55%
+1.6%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$6$12026-08-14: 4 insider purchases, $409K — WILLSEY LANCE, Rhodes Ryan, Schulz Fran, Shah Sanket2026-08: 4 open-market purchases, $409K↑ buys↓ salesdirector WILLSEY LANCE — Purchase on 2026-08-14, filed 3 days after the tradedirector Rhodes Ryan — Purchase on 2026-08-14, filed 3 days after the tradedirector Schulz Fran — Purchase on 2026-08-14, filed 3 days after the tradeofficer Shah Sanket — Purchase on 2026-08-14, filed 3 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-14WILLSEY LANCEdirectorPurchase50,000 @ $4.75$238K+4.0% of holding−11.8%not yet — horizon still open1,291,780Form 4 · filed 3 days after the trade
2026-08-14Rhodes RyandirectorPurchase21,000 @ $4.75$100K+3.5% of holding−11.8%not yet — horizon still open626,649Form 4 · filed 3 days after the trade
2026-08-14Schulz FrandirectorPurchase10,000 @ $4.75$48K+196.1% of holding−11.8%not yet — horizon still open15,100Form 4 · filed 3 days after the trade
2026-08-14Shah SanketofficerPurchase5,000 @ $4.75$24K+7.4% of holding−11.8%not yet — horizon still open72,500Form 4 · filed 3 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.